Menu Search
Equities

GlucoTrack Inc

GCTK:NAQ

GlucoTrack Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)0.36
  • Today's Change-1.21 / -77.06%
  • Shares traded6.58m
  • 1 Year change-55.69%
  • Beta0.0538
Data delayed at least 15 minutes, as of Nov 13 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year GlucoTrack Inc's net income fell 60.02% from a loss of 4.44m to a larger loss of 7.10m despite flat revenues.
Gross margin--
Net profit margin--
Operating margin--
Return on assets-251.32%
Return on equity-541.13%
Return on investment-493.89%
More ▼

Cash flow in USDView more

In 2023, GlucoTrack Inc increased its cash reserves by 93.14%, or 2.17m. Cash Flow from Financing totalled 8.73m or -- of revenues. In addition the company used 6.56m for operations while cash from investing was breakeven.
Cash flow per share-2.45
Price/Cash flow per share--
Book value per share-0.6004
Tangible book value per share-0.6004
More ▼

Balance sheet in USDView more

GlucoTrack Inc appears to have little financial risk as the company holds a substantial amount of cash on its books with little or no debt.
Current ratio0.1208
Quick ratio--
Total debt/total equity--
Total debt/total capital--
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.